Dalura, Zyrell S.
HRN: 22-77-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2023
CEFUROXIME 500MG (TAB)
03/28/2023
04/04/2023
PO
500mg
BID X 7 Days
2nd Degree Laceration; PROM X 6 Hrs
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes